A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

The US Food and Drug Administration (FDA) has approved Novo ... cardiovascular disease. Type 2 diabetes (T2D) patients with CKD will be eligible for the approval. The new indication makes Ozempic the ...

The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, developed by pharmaceutical company Novo Nordisk (NYSE:NVO). The medication is ...

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and ...

The Food and Drug Administration approved Novo ... chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA's decision means Ozempic can be ...

Share on Pinterest The FDA approved Ozempic to help lower chronic kidney disease-related risks in people with type 2 diabetes. urbazon/Getty Images The Food and Drug Administration (FDA ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

The US Food and Drug Administration (FDA ... Type 2 diabetes (T2D) patients with CKD will be eligible for the approval. The new indication makes Ozempic the first glucagon-like peptide-1 receptor ...

Please provide your email address to receive an email when new articles are posted on . The approval was supported by 1-year results from the phase 3 Pagoda study. Susvimo is also approved for wet ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes ... like peptide-1 (GLP-1) receptor agonist, or GLP-1 RA, known as semaglutide. The latest FDA ...